JCN VENTURES LIMITED
Company number 13274799 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JCN VENTURES LIMITED - Analysis Report
Company Number: 13274799
Analysis Date: 2025-07-20 17:50 UTC
Financial Health Assessment Report for JCN VENTURES LIMITED
1. Financial Health Score: D
Explanation:
The company displays symptoms of financial distress, notably negative net asset values (i.e., net liabilities) and a pattern of increasing current liabilities without corresponding current assets. This indicates a fragile balance sheet and potential solvency concerns. The low share capital and small asset base further limit financial resilience.
2. Key Vital Signs
| Metric | Latest (2024) | Interpretation |
|---|---|---|
| Net Assets (Equity) | -£10,120 | Negative equity: liabilities exceed assets, a critical warning sign of financial distress. |
| Current Liabilities | £10,120 | All liabilities are current, indicating short-term obligations must be met imminently. |
| Current Assets | £0 | No liquid assets to cover short-term debts; poor liquidity position. |
| Fixed Assets | £0 | No long-term assets to leverage for financing or collateral. |
| Share Capital | £1.00 | Minimal capital invested; limited buffer against losses. |
| Employees | 3 (average in 2024) | Small workforce consistent with micro-entity status but implies limited operational scale. |
Interpretation of Vital Signs:
- The negative net assets are like a "low red blood cell count" for the business, signaling weakened financial health.
- The absence of current assets to cover current liabilities reflects "poor circulation" of cash, risking an inability to meet immediate obligations.
- Minimal fixed assets and share capital indicate limited "structural strength," restricting capacity to absorb shocks or invest in growth.
3. Diagnosis
JCN VENTURES LIMITED is exhibiting clear symptoms of financial strain. The company’s balance sheet has deteriorated from a modest positive net asset position in 2021 (£5,100) to a negative net asset position by 2023 and 2024 (around -£10,000). This trend suggests ongoing losses or depletion of resources without replenishment.
The lack of current assets to cover liabilities is analogous to a patient with a "dehydrated bloodstream," meaning cash flow is insufficient to meet short-term debts, increasing default risk. The company’s micro-entity status and small workforce limit operational scale, and the minimal share capital provides little cushion.
Overall, the financial condition is precarious, with the company at risk of insolvency if the negative trend persists without corrective action.
4. Recommendations
To improve financial wellness and stabilize the business, the following steps are advised:
Improve Liquidity:
Inject working capital or secure short-term financing to create a "healthy cash flow," enabling the company to meet its immediate obligations.Reassess Cost Structure:
Review operational expenses and employee productivity to reduce overhead and preserve cash. Consider whether current staffing aligns with revenue generation.Asset Management:
Explore opportunities to acquire or leverage fixed assets that can serve as collateral for financing or improve operational efficiency.Capital Injection:
Increase share capital or seek external investment to strengthen the equity base, improving solvency and providing a buffer against future losses.Revenue Growth Strategy:
Develop or refine business plans to increase sales and profitability, addressing the root cause of asset depletion.Financial Monitoring:
Implement rigorous financial controls and regular monitoring to detect early warning signs and adjust strategies proactively.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.